SynBiotic SE (SBX.DE)

EUR 4.6

(-3.97%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 3.86 Million 8.16 Million 9.06 Million 5.47 Million - -
Cost of Revenue 2.35 Million 4.59 Million 3.86 Million 1.73 Million - -
Gross Profit 1.5 Million 3.57 Million 5.2 Million 3.73 Million - -
Operating Expenses 1.5 Million 28.97 Million 16.63 Million 4.45 Million 13.42 Thousand 822.00
Selling, General and Administrative Expenses 1.4 Million 2.67 Million 7.61 Million 3.61 Million 13.42 Thousand -
Research and Development Expenses - - - - - -
Other Expenses 100.88 Thousand 510.79 Thousand 16.63 Million 4.45 Million 13.42 Thousand 822.00
Cost and Expenses 11.44 Million 33.57 Million 20.49 Million 6.19 Million 13.42 Thousand 822.00
Operating Income -7.58 Million -24.61 Million -13.25 Million -722.71 Thousand -13.42 Thousand -822.00
Interest Expense 195.23 Thousand 188.89 Thousand 46.64 Thousand 22.87 Thousand - -
Income Tax Expense -134.9 Thousand -188.81 Thousand -289.71 Thousand 21.59 Thousand -13.42 Thousand -161.14 Thousand
Earnings before Tax -11.87 Million -26.18 Million -13.35 Million -858.79 Thousand -13.42 Thousand -822.00
Net Income -10.63 Million -24.36 Million -13.06 Million -880.38 Thousand -13.42 Thousand -822.00
Earnings Per Share Basic -2.24 -5.90 -4.21 -0.55 -0.05 -0.00
Earnings Per Share Diluted -2.24 -5.90 -4.21 -0.55 -0.05 -0.00
Weighted Average Shares Outstanding 4.74 Million 4.13 Million 3.1 Million 1.59 Million 260.07 Thousand 1.56 Million
Weighted Average Shares Outstanding (Diluted) 4.74 Million 4.13 Million 3.1 Million 1.59 Million 260.07 Thousand 1.56 Million
Gross Margin 0.39 0.44 0.57 0.68 - -
EBIT Margin -1.84 -0.75 -0.54 -0.11 - -
Profit Margin -2.75 -2.98 -1.44 -0.16 - -
EBITDA -7.12 Million -24.17 Million -10.61 Million -716.12 Thousand -1.00 -822.00
Earnings Before Tax Margin -1.96 -3.01 -1.46 -0.13 - -

Income Statement Charts